Evidence map›Paper›PMID 22308560›Full record

ArticleClinical trials (London, England)2012

Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial.

Catherine C Beauharnais, Mary E Larkin, Adrian H Zai, Emily C Boykin, Jennifer Luttrell, Deborah J Wexler

Open access · greenAbstract read
In one paragraph

Article in Clinical trials (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Real-Time Enrollment Dashboard For Multisite Clinical Trials.Contemporary clinical trials communications · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Catherine C BeauharnaisMassachusetts General Hospital Diabetes Center, Boston, MA 02114, USA.
Mary E Larkin
Adrian H Zai
Emily C Boykin
Jennifer Luttrell
Deborah J Wexler
Massachusetts General Hospital · US

Funding

Effective Inpatient Diabetes Management and the Transition to Outpatient CareK23DK080228 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI WEXLER, DEBORAH J · 2007 to 2011
$772k
NIDDK NIH HHS K23 DK 080 228NIDDK NIH HHS K23 DK080228
6 · The paper itself

Abstract

introductionScreening and recruitment for clinical trials can be costly and time-consuming. Inpatient trials present additional challenges because enrollment is time sensitive based on length of stay. We hypothesized that using an automated prescreening algorithm to identify eligible subjects would increase screening efficiency and enrollment and be cost-effective compared to manual review of a daily admission list.

methodsUsing a before-and-after design, we compared time spent screening, number of patients screened, enrollment rate, and cost-effectiveness of each screening method in an inpatient diabetes trial conducted at Massachusetts General Hospital. Manual chart review (CR) involved reviewing a daily list of admitted patients to identify eligible subjects. The automated prescreening (APS) method used an algorithm to generate a daily list of patients with glucose levels ≥ 180 mg/dL, an insulin order, and/or admission diagnosis of diabetes mellitus. The census generated was then manually screened to confirm eligibility and eliminate patients who met our exclusion criteria. We determined rates of screening and enrollment and cost-effectiveness of each method based on study sample size.

resultsTotal screening time (prescreening and screening) decreased from 4 to 2 h, allowing subjects to be approached earlier in the course of the hospital stay. The average number of patients prescreened per day increased from 13 ± 4 to 30 ± 16 (P < 0.0001). Rate of enrollment increased from 0.17 to 0.32 patients per screening day. Developing the computer algorithm added a fixed cost of US$3000 to the study. Based on our screening and enrollment rates, the algorithm was cost-neutral after enrolling 12 patients. Larger sample sizes further favored screening with an algorithm. By contrast, higher recruitment rates favored individual CR. LIMITATIONS: Because of the before-and-after design of this study, it is possible that unmeasured factors contributed to increased enrollment.

conclusionUsing a computer algorithm to identify eligible patients for a clinical trial in the inpatient setting increased the number of patients screened and enrolled, decreased the time required to enroll them, and was less expensive. Upfront investment in developing a computerized algorithm to improve screening may be cost-effective even for relatively small trials, especially when the recruitment rate is expected to be low.

Indexed as

AlgorithmsClinical Trials as TopicInpatientsPatient SelectionAutomationCost-Benefit AnalysisEfficiency, OrganizationalHospitals, GeneralHumansMassachusetts

Identifiers

PMID22308560
PMCPMC5222546
OpenAlexW1990252496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.